The expression of α-MSH by melanocytes is reduced in vitiligo

Annals of the New York Academy of Sciences

Volumn 885, Issue , 1999, Pages 470-473

  Graham, Alison ^c   Westerhof, Wiete ^a   Thody, Anthony J ^b  

^a Netherlands Institute for Pigment Disorders   (Netherlands)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; ANTIOXIDANT;

ADOLESCENT; ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MELANOCYTE; PATHOGENESIS; PROTEIN EXPRESSION; PUNCH BIOPSY; SCHOOL CHILD; VITILIGO;

EID: 0032786716     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08715.x     Document Type: Conference Paper

References (6)

1. 1. Schallreuter, K.U. et al. 1991. Low catalase levels in the epidermis of patients with vitiligo. J. Invest. Dermatol. 97: 1081-1085.
2. 2. Thody, A.J. et al. 1983. MSH peptides are present in mammalian skin. Peptides 4: 813-816.
3. 3. Valverde, P. et al. 1996. Tyrosinase may protect human melanocytes from the cytotoxic effects of the Superoxide anion. Exp. Dermatol. 5: 247-253.
4. 4. Wakamatsu, K. et al. 1997. Characterisation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. Pigment Cell Res. 10: 288-297.
5. 5. Seidah, N.G. et al. 1993. Mammalian paired basic amino acid convertases of prohormones and proproteins. Ann. N.Y. Acad. Sci. 680: 135-146.
6. 6. Thody, A.J. 1999. α-MSH and the regulation of melanocyte function. Ann. N.Y. Acad.Sci. 885: this volume.